Literature DB >> 19005755

Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.

Seyed Mohsen Dehghani1, Asma Erjaee, Mohammad Hadi Imanieh, Mahmood Haghighat.   

Abstract

OBJECTIVES: Helicobacter pylori (H. pylori) cure rates vary in different geographical regions because of differences in hosts as well as in H. pylori strains. In this study we evaluated the efficacy of different treatment regimens for eradication of H. pylori infection in children, in order to select a treatment regimen that is most effective with the least adverse effects and cost.
METHOD: Through a randomized clinical trial study we enrolled 120 pediatric patients (age <or= 18 years) with H. pylori infection confirmed through histopathological examination of their upper endoscopic findings and positive rapid urease test. Patients were randomized into three groups: group A received omeprazole, amoxicillin, metronidazole, and bismuth subcitrate; group B received omeprazole, amoxicillin, and clarithromycin; and group C the most recent regime of omeprazole, amoxicillin-clavulanic acid, and metronidazole. Subjects were followed 6 weeks after completing the antimicrobial therapy and H. pylori eradication was assessed with urea breath test.
RESULTS: A total of 117 patients with a mean age of 12 +/- 4 years completed the study. Eradication rate was 91.9% in group A, compared with 82.1% in group B, and 80.5% in group C (P = 0.33).
CONCLUSION: Considering these data we suggest quadruple therapy as the first line of therapy for eradication of H. pylori infection in children in our geographic area (Iran).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005755     DOI: 10.1007/s10620-008-0547-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Another therapeutic schedule in eradication of Helicobacter pylori.

Authors:  A Vcev; D Vuković; A Ivandić; A Vceva; B Dmitrović; D Kovacić; M Volaric; D Paulini; N Mićunović; D Horvat; S Mihaljević
Journal:  Acta Med Croatica       Date:  1997

Review 2.  The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?

Authors:  W A de Boer; G N Tytgat
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

Review 3.  Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.

Authors:  Javier P Gisbert; Leticia Gonzalez; Xavier Calvet
Journal:  Helicobacter       Date:  2005-06       Impact factor: 5.753

4.  Nodular gastritis and Helicobacter pylori.

Authors:  Y Bujanover; F Konikoff; M Baratz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-07       Impact factor: 2.839

5.  Results of triple eradication therapy in Japanese children: a retrospective multicenter study.

Authors:  Seiichi Kato; Mutsuko Konno; Shun-Ichi Maisawa; Hitoshi Tajiri; Norikazu Yoshimura; Toshiaki Shimizu; Shigeru Toyoda; Yoshiko Nakayama; Kazuie Iinuma
Journal:  J Gastroenterol       Date:  2004-09       Impact factor: 7.527

6.  Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.

Authors:  L A Fischbach; S van Zanten; J Dickason
Journal:  Aliment Pharmacol Ther       Date:  2004-11-15       Impact factor: 8.171

7.  Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate.

Authors:  V Ojetti; A Migneco; M A Zocco; E C Nista; G Gasbarrini; A Gasbarrini
Journal:  J Intern Med       Date:  2004-01       Impact factor: 8.989

8.  Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease.

Authors:  A Vcev; A Vceva; B Takac; B Dmitrović; D Stimac; T Stimac; D Kovac; D Pezerović; A Blazanović; A Ivandić; I Karner
Journal:  Acta Med Croatica       Date:  1998

9.  Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.

Authors:  Jungi Choi; Joo Young Jang; Joon Sung Kim; Hwa Young Park; Yon Ho Choe; Kyung Mo Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Intrafamilial clustering of Helicobacter pylori infection.

Authors:  B Drumm; G I Perez-Perez; M J Blaser; P M Sherman
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

View more
  6 in total

1.  Clinical trials report: optimal treatment of Helicobacter pylori gastric infection in children.

Authors:  Susan R Orenstein
Journal:  Curr Gastroenterol Rep       Date:  2010-06

2.  Bismuth salts in the treatment of Helicobacter pylori infection in children.

Authors:  Selim Gökçe
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

3.  Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children.

Authors:  Jeana Hong; Hye Ran Yang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2012-12-31

4.  Evaluation of the benefit of addition of clidinium C to a Helicobacter pylori eradication regimen.

Authors:  Maryam Chorami; Homayoun Zojaji; Nosratollah Naderi; Bijan Moghimi-Dehkordi; Dariush Mirsattari; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

5.  Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection.

Authors:  Ming-Cheh Chen; Wei-Yi Lei; Jen-Shung Lin; Chih-Hsun Yi; Deng-Chyang Wu; Chi-Tan Hu
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

6.  Is Helicobacter pylori infection a risk factor for childhood periodic syndromes?

Authors:  A Erjaee; M Haghighat; M Ataollahi; Y Daneshbod
Journal:  Int J Pediatr Adolesc Med       Date:  2015-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.